Malaria Vaccines Market Set to Exceed USD 156.8 million by 2026 Major Key Players: GlaxoSmithKline, GenVec, Inc., Nobelpharma, Sanaria, Cadila Healthcare Ltd., VLP Therapeutics LLC, CellFree Sciences Co. Ltd.

According to the new market research "Malaria Vaccines Market [By Agent (Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species); By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine); By Channel of Distribution (Hospitals, Clinics, Community Centers); By Regions (North America - U.S., Canada; Europe - Germany, UK, France; Asia-Pacific - China, India, Japan; Latin America - Brazil, Mexico; Middle East & Africa)]: Market size & Forecast, 2017 – 2026". The Global Malaria Vaccines market is expected to grow from USD 9.5 Million in 2017 to USD 156.8 Million by 2026, at a CAGR of 37.7% during the forecast period.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market/request-for-free-sample

Leading key players operating in the global malaria vaccines market are:

GlaxoSmithKline, GenVec, Inc., Nobelpharma,and Sanaria. Other promising vendors are Cadila Healthcare Ltd., CellFree Sciences Co. Ltd., Genome ReS Ltd., and VLP Therapeutics LLC, among others.

Malaria is a life-threatening blood disease caused by the mosquito plasmodium parasite. There are more than hundred varieties of plasmodium parasite can infect a variety of species. It may replicate at different rates, and affects the symptoms are escalate quickly, along with the severity of the disease. Malaria is known for causing symptoms that include vomiting, fever, tiredness, and headaches. At times, it may also cause seizures, coma, yellow skin, or even death in extreme cases. Among the various plasmodium species, four of them utilize humans as a natural intermediate host. These are P. ovale, P. vivax, P. falciparum, and P. malariae. Globally the demand for malaria vaccines is going to be further driven by the rising awareness related to the aftermaths of the disease, along with rising diagnosis and higher treatment rate.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market/inquire-before-buying

Based on data provided by WHO, in 2009 alone 214 Mn to 397 Mn cases of clinical malaria were reported worldwide. However, around 515 Mn clinical cases related to P. falciparum were projected in 2002. These growing incidences of malaria along with the presence of numerous companies that are introducing low profit margin vaccines is expected to boost the market growth for malaria vaccines market. However, it is expected that the high price of vaccines, weaker supply chain or distribution network in the developing countries, together with stringent regulatory policies may act as some main restraints for the market growth. It is also expected that the worldwide vaccination programs, research and development, technological breakthroughs and investments will likely provide new growth opportunities to the malaria vaccines in future.

A few key strategies adopted by companies present in the global malaria vaccines market are development in product, geographical expansion and supplying the products at a lower cost making it available to the poorest of countries. Based on the data provided by WHO (World Health Organization) there were more than 306,000 fatalities that were associated with malaria which was reported worldwide in 2015, out of which around 90% cases were found in Africa.

The global malaria vaccines market is divided on the basis of vaccine type, agent, channel of distribution and region. The channel of distribution used for malaria vaccines include the hospitals, clinics and community centers. Based on vaccine type the market is divided into pre- multi-antigen vaccine, erythrocytic vaccine, and erythrocytic vaccine. Considering the agent used in the malaria vaccines, the global market is segmented into plasmodium falciparum, plasmodium vivax, and anopheles species.

Browse Complete Summary of this report @ https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market/

Geographically, the Asia Pacific region is expected to grow at the fastest rate among all the other regions with Middle-east & Africa and Latin America likely to be the other potential regions for malaria vaccines market. Based on the data provided by WHO, more than 200 million cases of malaria were reported within the region of Africa in 2015 alone making the MEA or Middle-east and Africa as one of the largest potential regions that needs malaria vaccines.

Key Segments

Vaccines Type

• Pre-Erythrocytic Vaccine
• Erythrocytic Vaccine
• Multi-antigen Vaccine

Agent

• Plasmodium Falciparum
• Plasmodium Vivax
• Anopheles Species

Channel of Distribution

• Hospitals
• Clinics
• Community Centers

Region

• North America

o U.S.
o Canada

• Europe

o Germany
o UK
o France

• Asia-Pacific

o China
o India
o Japan

• Latin America

o Brazil
o Mexico

• Middle East and Africa

Download PDF Brochure- https://bit.ly/2JmERfQ

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: neel@polarismarketresearch.com

This release was published on openPR.